Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene

SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

Guex, N., & Peitsch, M. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,589 · see citing works

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · see citing works

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Vardiman, J., Thiele, J., Arber, D., Brunning, R., Borowitz, M., Porwit, A., Harris, N., Beau, M. L. L., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,837 · see citing works

Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)

McDonough, M. A., Li, V., Flashman, E., Chowdhury, R., Mohr, C., Liénard, B. M. R., Zondlo, J., Oldham, N. J., Clifton, I. J., Lewis, J. K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601283103 · Cited by 366 · see citing works

Signalling hypoxia by HIF hydroxylases

Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 343 · see citing works

A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis

Percy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508423103 · Cited by 330 · see citing works

<i>PHD2</i> Mutation and Congenital Erythrocytosis with Paraganglioma

Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., & Gardie, B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806277 · Cited by 323 · see citing works

Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases

Hirota, K., & Semenza, G. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.193 · Cited by 231 · see citing works

Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis

Semenza, G. L. (2009) · Blood · doi:10.1182/blood-2009-05-189985 · Cited by 225 · see citing works

A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove

Percy, M. J., Furlow, P. W., Beer, P. A., Lappin, T. R. J., McMullin, M. F., & Lee, F. S. (2007) · Blood · doi:10.1182/blood-2007-04-084434 · Cited by 155 · see citing works

The complete evaluation of erythrocytosis: congenital and acquired

Patnaik, M. M., & Tefferi, A. (2009) · Leukemia · doi:10.1038/leu.2009.54 · Cited by 124 · see citing works

Congenital polycythemias/erythrocytoses.

Gordeuk, V. R., Stockton, D. W., & Prchal, J. T. (2005) · PubMed · Cited by 104 · see citing works

Kinetic and crystallographic studies on deacetoxycephalosporin C synthase (DAOCS)

Lee, H. J., Lloyd, M. D., Harlos, K., Clifton, I. J., Baldwin, J. E., & Schofield, C. J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4649 · Cited by 102 · see citing works

Kinetic Rationale for Selectivity toward N- and C-terminal Oxygen-dependent Degradation Domain Substrates Mediated by a Loop Region of Hypoxia-Inducible Factor Prolyl Hydroxylases

Flashman, E., Bagg, E. A. L., Chowdhury, R., Mecinović, J., Loenarz, C., McDonough, M. A., Hewitson, K. S., & Schofield, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707411200 · Cited by 87 · see citing works

Idiopathic erythrocytosis: a disappearing entity

McMullin, M. F. (2009) · Hematology · doi:10.1182/asheducation-2009.1.629 · Cited by 56 · see citing works

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility

Astuti, D., Ricketts, C. J., Chowdhury, R., McDonough, M. A., Gentle, D., Kirby, G. A., Schlisio, S., Kenchappa, R. S., Carter, B. D., Kaelin, W. G., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0113 · Cited by 55 · see citing works

Disturbance in the HIF-1α pathway associated with erythrocytosis: Further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene

Al-Sheikh, M., Moradkhani, K., Lopez, M., Wajcman, H., & Préhu, C. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.017 · Cited by 50 · see citing works

Genetic causes of erythrocytosis and the oxygen-sensing pathway

Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 42 · see citing works

Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains

Villar, D., Vara-Vega, A., Landázuri, M. O., & del Peso, L. (2007) · Biochemical Journal · doi:10.1042/bj20071052 · Cited by 39 · see citing works

Genetically heterogeneous origins of idiopathic erythrocytosis

Percy, M. J. (2007) · Hematology · doi:10.1080/10245330601111979 · Cited by 32 · see citing works

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation

Bernardi, M., Ruggeri, M., Albiero, E., Madeo, D., & Rodeghiero, F. (2009) · American Journal of Hematology · doi:10.1002/ajh.21357 · Cited by 22 · see citing works

Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germ‐line mutation

Albiero, E., Ruggeri, M., Fortuna, S., Bernardi, M., Finotto, S., Madeo, D., & Rodeghiero, F. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08551.x · Cited by 17 · see citing works

Loss of the JAK2 intramolecular auto‐inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis

Albiero, E., Madeo, D., Ruggeri, M., Bernardi, M., Giorgetti, A., & Rodeghiero, F. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07180.x · Cited by 15 · see citing works

A new TMHA‐DHPLC assay for the rapid mutation screening of JAK2 exon 14 in myeloproliferative disorders

Albiero, E., Bernardi, M., Madeo, D., Ruggeri, M., & Rodeghiero, F. (2008) · American Journal of Hematology · doi:10.1002/ajh.21116 · Cited by 4 · see citing works

Regulation of erythropoiesis by hypoxia-inducible factors

Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787 · see citing works

A genetic mechanism for Tibetan high-altitude adaptation

Lorenzo, F., Huff, C. D., Myllymäki, M., Olenchock, B. A., Swierczek, S. I., Tashi, T., Gordeuk, V. R., Wuren, T., Ge, R., McClain, D. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3067 · Cited by 422 · see citing works

Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia

Yang, C., Zhuang, Z., Fliedner, S. M. J., Shankavaram, U. T., Sun, M. G., Bullova, P., Zhu, R., ELKAHLOUN, A. G., Kourlas, P. J., Merino, M. J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1205-7 · Cited by 146 · see citing works

Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases

Bento, C., Percy, M. J., Gardie, B., Maia, T. M., van Wijk, R., Perrotta, S., Ragione, F. D., Almeida, H., Rossi, C., Girodon, F., et al. (2013) · Human Mutation · doi:10.1002/humu.22448 · Cited by 123 · see citing works

Prolyl 4‐hydroxylases, master regulators of the hypoxia response

Myllyharju, J. (2013) · Acta Physiologica · doi:10.1111/apha.12096 · Cited by 118 · see citing works

Erythrocytosis: the HIF pathway in control

Franke, K., Gassmann, M., & Wielockx, B. (2013) · Blood · doi:10.1182/blood-2013-01-478065 · Cited by 112 · see citing works

Update on mutations in the HIF: EPO pathway and their role in erythrocytosis

Lappin, T. R. J., & Lee, F. S. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100590 · Cited by 82 · see citing works

Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes

Tojo, Y., Sekine, H., Hirano, I., Pan, X., Souma, T., Tsujita, T., Kawaguchi, S., Takeda, N., Takeda, K., Fong, G., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00161-15 · Cited by 70 · see citing works

Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis

Laitala, A., Aro, E., Walkinshaw, G., Mäki, J. M., Rossi, M., Heikkilä, M., Savolainen, E.-R., Arend, M., Kivirikko, K. I., Koivunen, P., et al. (2012) · Blood · doi:10.1182/blood-2012-07-441824 · Cited by 58 · see citing works

Inherited predisposition to myeloproliferative neoplasms

Jones, A. V., & Cross, N. C. P. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713489144 · Cited by 53 · see citing works

Overview of Myeloproliferative Neoplasms

Tremblay, D. A., Yacoub, A., & Hoffman, R. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.12.001 · Cited by 52 · see citing works

The role of PHD2 mutations in the pathogenesis of erythrocytosis

Gardie, B., Percy, M. J., Hoogewijs, D., Chowdhury, R., Bento, C., McMullin, M. F., Schofield, C. J., Lee, F. S., Richard, S., Arsenault, P. R., et al. (2014) · Hypoxia · doi:10.2147/hp.s54455 · Cited by 51 · see citing works

Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?)

Bento, C., Almeida, H., Maia, T. M., Relvas, L., Oliveira, A. C., Rossi, C., Girodon, F., Fernández-Lago, C., Aguado‐Diaz, A., Fraga, C., et al. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12170 · Cited by 46 · see citing works

Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes

Urrutia, A. A., Afzal, A., Nelson, J., Davidoff, O., Gross, K. W., & Haase, V. H. (2016) · Blood · doi:10.1182/blood-2016-05-713545 · Cited by 44 · see citing works

Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia

Frost, J., Frost, M. G., Batie, M., Jiang, H., & Rocha, S. (2021) · Cancers · doi:10.3390/cancers13020350 · Cited by 47 · see citing works

HIF pathway mutations and erythrocytosis

McMullin, M. F. (2010) · Expert Review of Hematology · doi:10.1586/ehm.09.68 · Cited by 25 · see citing works

Hereditary erythrocytosis, thrombocytosis and neutrophilia

Hong, W., & Gotlib, J. R. (2014) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2014.07.002 · Cited by 22 · see citing works

Why Does My Patient Have Erythrocytosis?

Kremyanskaya, M., Mascarenhas, J. O., & Hoffman, R. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.02.011 · Cited by 20 · see citing works

Characterization of blood donors with high haemoglobin concentration

Magnussen, K., Hasselbalch, H. C., Ullum, H., & Bjerrum, O. W. (2012) · Vox Sanguinis · doi:10.1111/j.1423-0410.2012.01644.x · Cited by 18 · see citing works

An EGLN1 mutation may regulate hypoxic response in cyanotic congenital heart disease through the PHD2/HIF-1A pathway

Zhou, Y., Ouyang, N., Liu, L., Tian, J., Huang, X., & Lu, T. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.03.003 · Cited by 15 · see citing works

Erythrocytosis due toPHD2Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics

Wilson, R. C., Syed, N., & Shah, P. C. (2016) · Case Reports in Hematology · doi:10.1155/2016/6373706 · Cited by 15 · see citing works

Hereditary gene mutations in Korean patients with isolated erythrocytosis

Jang, J., Seo, J. Y., Jang, J., Jung, C. W., Lee, K.-O., Kim, S., & Kim, H. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2006-3 · Cited by 13 · see citing works

Computational analysis of prolyl hydroxylase domain-containing protein 2 (PHD2) mutations promoting polycythemia insurgence in humans

Minervini, G., Quaglia, F., & Tosatto, S. C. E. (2016) · Scientific Reports · doi:10.1038/srep18716 · Cited by 12 · see citing works

Zebrafish mutants in egln1 display a hypoxic response and develop polycythemia

Dou, X., Chen, Z., Liu, Y., Li, Y., Ye, J., & Lü, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122564 · Cited by 10 · see citing works

Congenital erythrocytosis – discover of a new mutation in the EGLN1 gene

Barradas, J., Rodrigues, C. D., Ferreira, G., Rocha, P., Constanço, C., Andrade, M. R., Bento, C., & Silva, H. M. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1499 · Cited by 8 · see citing works

The Polycythemias

Kremyanskaya, M., Najfeld, V., Mascarenhas, J. O., & Hoffman, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00068-8 · Cited by 5 · see citing works

Hypoxia-inducible factor prolyl 4-hydroxylase-2 in Tibetan high-altitude adaptation, extramedullary erythropoiesis and skeletal muscle ischemia

Myllymäki, M. (2016) · Cited by 3 · see citing works

Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the EGLN1 Gene

Moore, J. A., Hubbi, M. E., Wang, C., Wang, Y., Luo, W., Hofmann, S. L., & Rambally, S. (2020) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709620947256 · Cited by 3 · see citing works

Disturbance in the HIF-1α pathway associated with erythrocytosis: Further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene

Al-Sheikh, M., Moradkhani, K., Lopez, M., Wajcman, H., & Préhu, C. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.017 · Cited by 50 · see citing works

The role of PHD2 mutations in the pathogenesis of erythrocytosis

Gardie, B., Percy, M. J., Hoogewijs, D., Chowdhury, R., Bento, C., McMullin, M. F., Schofield, C. J., Lee, F. S., Richard, S., Arsenault, P. R., et al. (2014) · Hypoxia · doi:10.2147/hp.s54455 · Cited by 51 · see citing works

Two new mutations in the <i>HIF2A</i> gene associated with erythrocytosis

Percy, M. J., Chung, Y. J., Harrison, C., Mercieca, J., Hoffbrand, A. V., Dinardo, C. L., Santos, P. C. J. L., Fonseca, G. H. H., Gualandro, S. F. M., Pereira, A. C., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23123 · Cited by 37 · see citing works

Familial Erythrocytosis Associated with a Mutation in the HIF Prolyl Hydroxylase, PHD2.

Percy, M. J., Zhao, Q., Flores, A., Harrison, C. N., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. (2005) · Blood · doi:10.1182/blood.v106.11.127.127 · Cited by 2 · see citing works

Update on mutations in the HIF: EPO pathway and their role in erythrocytosis

Lappin, T. R. J., & Lee, F. S. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100590 · Cited by 82 · see citing works